Chairman and CEO Hong Zhi increased his holdings in BRII-B (02137) by 58,000 shares at a price of approximately 1.02 Hong Kong dollars per share.

17:51 24/09/2024

On September 23, Chairman and CEO Hong Zhi of the board of directors increased his holdings of Tengsheng Pharmaceutical-B (02137) by 58,000 shares, with a price of 1.0195 Hong Kong dollars per share, totaling approximately 59,100 Hong Kong dollars.

According to the latest information from the Hong Kong Stock Exchange, on September 23, the Chairman of the Board and CEO, Hong Zhi, increased his holdings of BRII-B (02137) by 58,000 shares at a price of 1.0195 Hong Kong dollars per share, with a total amount of approximately 59,100 Hong Kong dollars. After the increase, the latest number of shares held is approximately 54.5678 million shares, with a new shareholding ratio of 7.46%.

New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.